SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer

Background: Prostate cancer is a major global challenge due to the increasing number of aging population and frequency of diagnosis. During the past decade new treatments have been targeted to the androgen signaling axis either by inhibiting the binding of androgens to androgen receptor (AR) and AR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Autores principales: Oksala, Riikka, Karimaa, Mari, Riikonen, Reetta, Räsänen, Kati, Ramela, Meri, Vehmaan-Kreula, Pirjo, Rummakko, Petteri, Wohlfahrt, Gerd, Mustonen, Mika
Formato: Artigo
Lenguaje:Inglês
Publicado: Endocrine Society 2019
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553147/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares